Home/Filings/4/0001562180-23-004477
4//SEC Filing

Chardonnet Laurent 4

Accession 0001562180-23-004477

CIK 0001678660other

Filed

May 24, 8:00 PM ET

Accepted

May 25, 4:05 PM ET

Size

5.1 KB

Accession

0001562180-23-004477

Insider Transaction Report

Form 4
Period: 2023-05-23
Chardonnet Laurent
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2023-05-23$5.50/sh+5,000$27,50042,165 total
Footnotes (1)
  • [F1]The reported total includes 1,292 shares of common stock the reporting person has acquired since the date of his last ownership report through the issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c).

Issuer

Prelude Therapeutics Inc

CIK 0001678660

Entity typeother

Related Parties

1
  • filerCIK 0001329010

Filing Metadata

Form type
4
Filed
May 24, 8:00 PM ET
Accepted
May 25, 4:05 PM ET
Size
5.1 KB